Psychotic Disorders - Argentina | Statista Market Forecast

Revenue in the Psychotic Disorders market is projected to reach US$62.07m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of -1.07%, resulting in a market volume of US$58.82m by 2029.
In global comparison, most revenue will be generated United States (US$2.26bn in 2024).
In relation to total population figures, per person revenues of US$92.95 are generated in 2024.

Psychotic disorders are severe mental health disorders that cause changes in a person's way of thinking and their perception. Patients often have trouble differentiating between what they perceive and reality. Different types of psychotic disorders include schizophrenia, bipolar disorder, substance-induced psychotic disorder, delusional disorder, and brief psychotic disorder. However, this market only represents the sales of antipsychotic drugs that are used to treat schizophrenia and bipolar disorder.

Market values represent the revenues generated by manufacturers and are based on retail prices for each drug category including all drugs, regardless of whether they are reimbursed or not.

Company examples: Otsuka Pharmaceutical, Lundbeck, AbbVie, Allergan plc, Recordati S.p.A., Gadeon Richter, Sumitomo Pharma, Johnson & Johnson / Janssen, Vanda Pharmaceuticals, Alkermes, Eli Lilly, AstraZeneca, and Intra-Cellular Therapies

Antipsychotic drugs: Aripiprazole (Abilify), Asenapine (Saphris), Cariprazine (Vraylar), Clozapine (Clozaril, Versacloz), lumateperone (Caplyta), Lurasidone (Latuda), Olanzapine (Zyprexa), Quetiapine (Seroquel), Risperidone (Risperdal), Risperidone (Aristada), Ziprasidone (Geodon), Brexpiprazole (Rexulti), Iloperidone (Fanapt), and Paliperidone (Invega)

Psychotherapy
Talk therapy
Herbal medicines
Digital health apps
Deep Brain Stimulation (DBS)

The Psychotic Disorders market in Argentina is experiencing steady growth due to several factors. Customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors all contribute to the development of this market.

Customer preferences: In Argentina, there is a growing awareness and acceptance of mental health issues, including psychotic disorders. As a result, there is an increasing demand for effective treatment options and support services. Customers are seeking treatments that not only alleviate symptoms but also improve their overall quality of life. They are looking for personalized and holistic approaches that address their unique needs and preferences. Additionally, there is a preference for therapies that have minimal side effects and are backed by scientific evidence.

Trends in the market: One of the key trends in the Psychotic Disorders market in Argentina is the adoption of innovative therapies. Pharmaceutical companies are investing in research and development to introduce new and improved medications that target the underlying causes of psychotic disorders. These therapies aim to provide better symptom relief and reduce the risk of relapse. Additionally, there is a growing interest in non-pharmacological interventions such as cognitive-behavioral therapy and psychosocial support programs. These approaches focus on helping individuals manage their symptoms and improve their overall well-being.

Local special circumstances: Argentina has a well-established healthcare system that provides access to mental health services. There are specialized clinics and hospitals that cater specifically to individuals with psychotic disorders. Moreover, the government has implemented policies and programs to promote mental health and improve access to treatment. This includes the provision of subsidies for medications and therapies, as well as the integration of mental health services into primary care settings. These initiatives contribute to the growth of the Psychotic Disorders market in Argentina by increasing awareness, reducing stigma, and improving access to care.

Underlying macroeconomic factors: The economic stability and growth of Argentina play a significant role in the development of the Psychotic Disorders market. A stable economy provides individuals with the means to seek and afford treatment. Additionally, a growing middle class and increased disposable income contribute to the demand for healthcare services, including mental health treatments. Furthermore, the government's commitment to investing in healthcare infrastructure and improving access to quality care creates a conducive environment for the growth of the Psychotic Disorders market.In conclusion, the Psychotic Disorders market in Argentina is developing due to customer preferences for personalized and holistic treatments, the adoption of innovative therapies, local special circumstances such as a well-established healthcare system and government initiatives, and underlying macroeconomic factors such as economic stability and government investments in healthcare. These factors collectively contribute to the steady growth of the market and the improved availability of treatment options for individuals with psychotic disorders in Argentina.

Data coverage:

Data encompasses B2C enterprises. Figures are based on companies' revenues, international institutes data, and global consumer survey data. Revenues refer to the retail value and include sales taxes.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use financial reports and third-party data. Next, we use relevant key market indicators and data from country-specific associations such as healthcare spending per capita, medical product spending per capita, and gross domestic product per capita. This data helps us to estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, S-Curve function, ARIMA time series model and exponential curve function. Data is modeled using current exchange rates.

Additional Notes:

The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Despite what some may think, mental health problems are common in the United States and around the world. Mental health issues, much like other health issues, can be mild, but can also be life altering, affecting the emotional, social, and psychological well-being of the person. Common types of mental illness include mood disorders, anxiety disorders, eating disorders, and personality disorders. Although symptoms of mental illness differ depending on the type of illness and seriousness of the problem, common symptoms of mental health issues include changes in sleeping and eating habits, social withdrawal, feelings of hopelessness, anger, and prolonged sadness, suicidal thoughts, and substance abuse. In 2022, it was estimated that around 36 percent of those in the U.S. aged 18 to 25 years and 29 percent of those aged 26 to 49 years suffered from some form of mental illness in the past year.